Covid-19 Vaccine: Oman Approves Bharat Biotech's Covaxin Under New Travel Rules

The passengers from India who have received two doses of Covaxin at-least 14 days before the estimated arrival date won't be subjected to quarantine upon arrival in Oman.

Outlook Web Desk

Updated on: 28 October 2021 12:50 pm

Bharat Biotech's Covaxin has been included to the approved list of Covid-19 vaccines for travel to Oman without quarantine.

Bharat Biotech retweeted a press release tweeted by the embassy of India in Muscat, Oman which informed about the approval of Covaxin in the gulf nation,

ðÂÂÂÂÂÂ¢ COVAXIN has now been added to the approved list of #COVID19 vaccines ðÂÂÂÂÂÂÂÂÂ for travel to Oman without quarantine. This will facilitate travelers from India vaccinated with COVAXIN.

Please see Press Release ðÂÂÂÂÂÂÂÂÂ@PMOIndia @DrSJaishankar @MEAIndia @IndianDiplomacy pic.twitter.com/3lfXPrjHGc
— India in Oman (Embassy of India, Muscat) (@Indemb_Muscat) October 27, 2021

"Embassy of India, Muscat, is pleased to inform that the Government of the Sultanate of Oman has added Covaxin to the approved list of Covid-19 vaccines for travel to Oman. The Civil Aviation Authority issued a notification on 27 October regarding this," the release stated.

All passengers from India who have received two doses of Covaxin at-least 14 days before the estimated arrival date will now be able to travel to Oman without the requirement of quarantine, it added.

All other Covid-19 related requirements/conditions, such as pre-arrival RT-PCR test shall be applicable for such passengers, the release stated.

This notification will significantly ease travel to Oman for Indian nationals who have taken Covaxin, it noted.

Passengers who have taken AstraZeneca/Covishield are already permitted to travel to Oman without quarantine.

(With PTI Inputs)